IRIS publication 12012129
Multi-Stage Protection against Malaria using Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1.
RIS format for Endnote and similar
TY - JOUR - Draper S.J, Moore A.C., Goodman A.L., Long C.A., Holder A.A., Gilbert S.C., Hill F., Hill A.V.S. - 2008 - January - Nature Medicine - Multi-Stage Protection against Malaria using Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1. - Published - Altmetric: 1 () - 14 - 819 - 821 - Protein-in-adjuvant vaccines have shown limited success against difficult diseases such as blood-stage malaria. Here we show that a recombinant adenovirus-poxvirus prime-boost immunization regime (known to induce strong T cell immunogenicity) can also induce very strong antigen-specific antibody responses, and we identify a simple complement-based adjuvant to further enhance immunogenicity. Antibodies induced against a blood-stage malaria antigen by this viral vector platform are highly effective against Plasmodium yoelii parasites in mice and against Plasmodium falciparum in vitro. - http://www.nature.com/nm/journal/v14/n8/abs/nm.1850.html - 10.1038/nm.1850 DA - 2008/01 ER -
BIBTeX format for JabRef and similar
@article{V12012129, = {Draper S.J, Moore A.C. and Goodman A.L., Long C.A. and Holder A.A., Gilbert S.C. and Hill F., Hill A.V.S. }, = {2008}, = {January}, = {Nature Medicine}, = {Multi-Stage Protection against Malaria using Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1.}, = {Published}, = {Altmetric: 1 ()}, = {14}, pages = {819--821}, = {{Protein-in-adjuvant vaccines have shown limited success against difficult diseases such as blood-stage malaria. Here we show that a recombinant adenovirus-poxvirus prime-boost immunization regime (known to induce strong T cell immunogenicity) can also induce very strong antigen-specific antibody responses, and we identify a simple complement-based adjuvant to further enhance immunogenicity. Antibodies induced against a blood-stage malaria antigen by this viral vector platform are highly effective against Plasmodium yoelii parasites in mice and against Plasmodium falciparum in vitro. }}, = {http://www.nature.com/nm/journal/v14/n8/abs/nm.1850.html}, = {10.1038/nm.1850}, source = {IRIS} }
Data as stored in IRIS
AUTHORS | Draper S.J, Moore A.C., Goodman A.L., Long C.A., Holder A.A., Gilbert S.C., Hill F., Hill A.V.S. | ||
YEAR | 2008 | ||
MONTH | January | ||
JOURNAL_CODE | Nature Medicine | ||
TITLE | Multi-Stage Protection against Malaria using Recombinant Viral Vaccines Expressing Merozoite Surface Protein-1. | ||
STATUS | Published | ||
TIMES_CITED | Altmetric: 1 () | ||
SEARCH_KEYWORD | |||
VOLUME | |||
ISSUE | 14 | ||
START_PAGE | 819 | ||
END_PAGE | 821 | ||
ABSTRACT | Protein-in-adjuvant vaccines have shown limited success against difficult diseases such as blood-stage malaria. Here we show that a recombinant adenovirus-poxvirus prime-boost immunization regime (known to induce strong T cell immunogenicity) can also induce very strong antigen-specific antibody responses, and we identify a simple complement-based adjuvant to further enhance immunogenicity. Antibodies induced against a blood-stage malaria antigen by this viral vector platform are highly effective against Plasmodium yoelii parasites in mice and against Plasmodium falciparum in vitro. | ||
PUBLISHER_LOCATION | |||
ISBN_ISSN | |||
EDITION | |||
URL | http://www.nature.com/nm/journal/v14/n8/abs/nm.1850.html | ||
DOI_LINK | 10.1038/nm.1850 | ||
FUNDING_BODY | |||
GRANT_DETAILS |